Vircell – Strongyloides Stercoralis VirClia IgG Monotest

Strongyloides is the only worm that can persist in the gastrointestinal tract without symptoms for decades and is often underdiagnosed. The asymptomatic infection carries a significant risk of severe hyperinfection in:

• Organ transplant recipients from asymptomatic organ donors
• Patients with haematological malignancies
• Systemic corticosteroid users
• Faecal microbiota transplantation recipients from an asymptomatic faecal donor

The Strongyloides Stercoralis VirClia IgG Monotest is the first and only CLIA assay that delivers accurate, same-day strongyloidiasis diagnosis.

Key benefits of the Strongyloides Monotest assay:

• CLIA test with random access and continuous loading for immediate diagnosis of S. stercoralis infection.
• Excellent sensitivity (94%) and specificity (93%).
• Adapted to urgent diagnosis – Rapid, automated protocol, results in around 1h.
• No sample cumulation compared to ELISA.
• Same-day results for urgent samples prior to organ transplantation or immunosuppressive therapy initiation.
• Compatible with the VirClia portfolio ~100 different assays.

Key benefits patients and providers:

• Improves patient care, better patient management.
• Avoids hyperinfection in asymptomatic infected patients by systemic corticoid treatment.
• Avoids transplant complications in patient at risk due to hyperinfection by immunosuppressive therapy.
• Allows early antiparasitic therapy to be started, when needed before too late.
• Harmful high doses of Ivermectin.
• Improve health economics: reduce high ICU cost associated to long stays.
• May assess therapy success by significant reduction in pre- and post-treatment reactivity.

Benefits of Monotest CLIA assays:

• On-demand testing: One monotest= one reportable test. Nothing else is required.
• Individual quality control per monotest, no need for extra controls or calibrations.
• Random access automated protocol with results in 1 hour
• Same day results, no batching, no sample cumulation

THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.

Go Back